Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ, Kwekkeboom DJ, Valkema R, Krenning EP. Teunissen JJ, et al. Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51. doi: 10.1530/ERC-10-0282. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 22005114 Review.
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?
ten Kate GL, Sijbrands EJ, Valkema R, ten Cate FJ, Feinstein SB, van der Steen AF, Daemen MJ, Schinkel AF. ten Kate GL, et al. J Nucl Cardiol. 2010 Oct;17(5):897-912. doi: 10.1007/s12350-010-9263-x. J Nucl Cardiol. 2010. PMID: 20552308 Free PMC article. Review.
Prediction of 9-year cardiovascular outcomes by myocardial perfusion imaging in patients with normal exercise electrocardiographic testing.
Schinkel AF, Boiten HJ, van der Sijde JN, Ruitinga PR, Sijbrands EJ, Valkema R, van Domburg RT. Schinkel AF, et al. Eur Heart J Cardiovasc Imaging. 2012 Nov;13(11):900-4. doi: 10.1093/ehjci/jes104. Epub 2012 May 15. Eur Heart J Cardiovasc Imaging. 2012. PMID: 22588207
Dobutamine stress myocardial perfusion imaging: 8-year outcomes in patients with diabetes mellitus.
Boiten HJ, van Domburg RT, Valkema R, Zijlstra F, Schinkel AF. Boiten HJ, et al. Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):871-6. doi: 10.1093/ehjci/jev351. Epub 2016 Jan 19. Eur Heart J Cardiovasc Imaging. 2016. PMID: 26792936
12-Year outcome after normal myocardial perfusion SPECT in patients with known coronary artery disease.
Ottenhof MJ, Wai MC, Boiten HJ, Korbee RS, Valkema R, van Domburg RT, Schinkel AF. Ottenhof MJ, et al. J Nucl Cardiol. 2013 Oct;20(5):748-54. doi: 10.1007/s12350-013-9713-3. Epub 2013 Aug 3. J Nucl Cardiol. 2013. PMID: 23912382
15-Year outcome after normal exercise ⁹⁹mTc-sestamibi myocardial perfusion imaging: what is the duration of low risk after a normal scan?
Schinkel AF, Boiten HJ, van der Sijde JN, Ruitinga PR, Sijbrands EJ, Valkema R, van Domburg RT. Schinkel AF, et al. J Nucl Cardiol. 2012 Oct;19(5):901-6. doi: 10.1007/s12350-012-9587-9. Epub 2012 Jun 8. J Nucl Cardiol. 2012. PMID: 22678852 Free PMC article.
Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability.
Schinkel AF, Bax JJ, Biagini E, Elhendy A, van Domburg RT, Valkema R, Rizzello V, Schouten O, Simoons M, Poldermans D. Schinkel AF, et al. Am J Cardiol. 2005 May 15;95(10):1223-5. doi: 10.1016/j.amjcard.2005.01.050. Am J Cardiol. 2005. PMID: 15877995
Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, Rizzello V, Agricola E, Valkema R, Roelandt JR, Poldermans D. Schinkel AF, et al. Am J Cardiol. 2003 Feb 15;91(4):408-11. doi: 10.1016/s0002-9149(02)03234-4. Am J Cardiol. 2003. PMID: 12586253
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.
Rolleman EJ, Melis M, Valkema R, Boerman OC, Krenning EP, de Jong M. Rolleman EJ, et al. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1018-31. doi: 10.1007/s00259-009-1282-y. Epub 2009 Nov 14. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915842 Review.
Peptide-receptor radionuclide therapy for endocrine tumors.
van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ. van Essen M, et al. Nat Rev Endocrinol. 2009 Jul;5(7):382-93. doi: 10.1038/nrendo.2009.105. Epub 2009 Jun 2. Nat Rev Endocrinol. 2009. PMID: 19488074 Review.
161 results
Jump to page
Feedback